Foot-and-mouth disease virus 3C protease: Recent structural and functional insights into an antiviral target

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 1, 2007, Pages 1-6

  Curry, Stephen ^a   Roqué Rosell, Núria ^b   Zunszain, Patricia A ^a   Leatherbarrow, Robin J ^b  

^a Blackett Laboratory   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

3C protease; Anti viral drugs; Foot and mouth disease virus; Peptide cleavage specificity; Protease mechanism

Indexed keywords

ANTIVIRUS AGENT; POLYPROTEIN; PROTEINASE; RNA; VIRUS VACCINE;

AMINO ACID SEQUENCE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CATALYSIS; DRUG TARGETING; ECONOMIC ASPECT; ENZYME STRUCTURE; FOOT AND MOUTH DISEASE VIRUS; GENOMICS; HYDROPHILICITY; HYDROPHOBICITY; MESSENGER RNA SYNTHESIS; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA REPLICATION; SHORT SURVEY; STRUCTURE ANALYSIS; VIRAL GENETICS; VIRUS PATHOGENESIS;

ANIMALS; CYSTEINE ENDOPEPTIDASES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; PROTEIN PRECURSORS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RNA; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

FOOT-AND-MOUTH DISEASE VIRUS;

EID: 33749649170     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.07.006     Document Type: Short Survey

References (33)

1. Allaire M., Chernaia M.M., Malcolm B.A., and James M.N. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 369 6475 (1994) 72-76
2. Anand K., Palm G.J., Mesters J.R., Siddell S.G., Ziebuhr J., and Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J. 27 13 (2002) 3213-3224
3. Barrett A.J., and Rawlings N.D. Evolutionary lines of cysteine peptidases. Biol. Chem. 382 5 (2001) 727-733
4. Belsham G.J., Mclnerney G.M., and Ross-Smith N. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J. Virol. 74 1 (2000) 272-280
5. Bergmann E.M., Cherney M.M., McKendrick J., Frormann S., Luo C., Malcolm B.A., et al. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV. Virology 265 1 (1999) 153-163
6. Bergmann E.M., Mosimann S.C., Chernaia M.M., Malcolm B.A., and James M.N. The refined crystal structure of the 3C gene product from hepatitis A virus: Specific proteinase activity and RNA recognition. J. Virol. 77 3 (1997) 2436-2448
7. Birtley J.R., Knox S.R., Jaulent A.M., Brick P., Leatherbarrow R.J., and Curry S. Crystal structure of foot-and-mouth disease virus 3C protease: New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 280 12 (2005) 11520-11527
8. Blom N., Hansen J., Blaas D., and Brunak S. Cleavage site analysis in picornaviral polyproteins: Discovering cellular targets by neural networks. Protein Sci. 5 11 (1996) 2203-2216
9. Brenner S. The molecular evolution of genes and proteins: A tale of two serines. Nature 334 6182 (1988) 528-530
10. Carrillo C., Tulman E.R., Delhon G., Lu Z., Carreno A., Vagnozzi A., et al. Comparative genomics of foot-and-mouth disease virus. J. Virol. 79 10 (2005) 6487-6504
11. Dragovich P.S., Prins T.J., Zhou R., Brown E.L., Maldonado F.C., Fuhrman S.A., et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable 2-pyridone-containing peptidomimetics. J. Med. Chem. 45 8 (2002) 1607-1623
12. Falk M.M., Grigera P.R., Bergmann I.E., Zibert A., Multhaup G., and Beck E. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J. Virol. 64 2 (1990) 748-756
13. Grubman M.J., and Baxt B. Foot-and-mouth disease. Clin. Microbiol. Rev. 77 2 (2004) 465-493
14. Grubman M.J., Zellner M., Bablanian G., Mason P.W., and Piccone M.E. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 213 2 (1995) 581-589
15. Hedstrom L. Serine protease mechanism and specificity. Chem. Rev. 102 12 (2002) 4501-4524
16. Kean K.M., Teterina N.L., Marc D., and Girard M. Analysis of putative active site residues of the poliovirus 3C protease. Virology 757 2 (1991) 609-619
17. Khan A.R., Khazanovich-Bernstein N., Bergmann E.M., and James M.N. Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors. Proc. Natl. Acad. Sci. U.S.A. 96 20 (1999) 10968-10975
18. Leong L.E.-C., Cornell C.T., and Semler B.L. Processing determinants and functions of cleavage products of picornavirus proteins. In: Semler B.L., and Wimmer E. (Eds). Molecular Biology of Picornaviruses (2002), ASM Press, Washington, DC 187-197
19. Li W., Ross-Smith N., Proud C.G., and Belsham G.J. Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: Identification of the eIF4AI cleavage site. FEBS Lett. 507 1 (2001) 1-5
20. Mason P.W., Grubman M.J., and Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 97 1 (2003) 9-32
21. Matthews D.A., Dragovich P.S., Webber S.E., Fuhrman S.A., Patick A.K., Zalman L.S., et al. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. U.S.A. 96 20 (1999) 11000-11007
22. Matthews D.A., Smith W.W., Ferre R.A., Condon B., Budahazi G., Sisson W., et al. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77 5 (1994) 761-771
23. Mosimann S.C., Cherney M.M., Sia S., Plotch S., and James M.N. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J. Mol. Biol. 273 5 (1997) 1032-1047
24. Nayak A., Goodfellow I.G., and Belsham G.J. Factors required for the uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J. Virol. 79 12 (2005) 7698-7706
25. Nayak A., Goodfellow I.G., Woolaway K.E., Birtley J.R., Curry S., and Belsham G.J. Role of RNA structure and RNA binding activity of the foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication. J. Virol. 80 19 (2006) 9865-9875
26. Phan J., Zdanov A., Evdokimov A.G., Tropea J.E., Peters III H.K., Kapust R.B., et al. Structural basis for the substrate specificity of tobacco etch virus protease. J. Biol. Chem. 277 52 (2002) 50564-50572
27. Sarkany Z., and Polgar L. The unusual catalytic triad of poliovirus protease 3C. Biochemistry 42 2 (2003) 516-522
28. Sarkany Z., Szeltner Z., and Polgar L. Thiolate-imidazolium ion pair is not an obligatory catalytic entity of cysteine peptidases: The active site of picornain 3C. Biochemistry 40 35 (2001) 10601-10606
29. Seipelt J., Guarne A., Bergmann E., James M., Sommergruber W., Fita I., et al. The structures of picornaviral proteinases. Virus Res. 62 2 (1999) 159-168
30. Skern T., Hampoelz B., Guarne A., Fita I., Bergmann E., Petersen J., et al. Structure and function of picornavirus proteases. In: Semler B.L., and Wimmer E. (Eds). Molecular Biology of Picornaviruses (2002), ASM Press, Washington, DC 199-212
31. Sweeney, T. R., Roque-Rosell, N., Birtley, J.R., Leatherbarrow, R. J., & Curry, S. (2006). Unpublished results.
32. Yin J., Bergmann E.M., Cherney M.M., Lall M.S., Jain R.P., Vederas J.C., et al. Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: Selective crystallization and formation of a functional catalytic triad in the active site. J. Mol. Biol. 354 4 (2005) 854-871
33. Zeitler C.E., Estes M.K., and Prasad B.V. X-ray cry stall ographic structure of the Norwalk virus protease at 1.5 Å resolution. J. Virol. 50 10 (2006) 5050-5058